JP2016521684A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521684A5
JP2016521684A5 JP2016515094A JP2016515094A JP2016521684A5 JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5 JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5
Authority
JP
Japan
Prior art keywords
solution
hypochlorous acid
magnesium
amount
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016515094A
Other languages
English (en)
Japanese (ja)
Other versions
JP6416227B2 (ja
JP2016521684A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/039202 external-priority patent/WO2014190184A1/en
Publication of JP2016521684A publication Critical patent/JP2016521684A/ja
Publication of JP2016521684A5 publication Critical patent/JP2016521684A5/ja
Application granted granted Critical
Publication of JP6416227B2 publication Critical patent/JP6416227B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016515094A 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用 Expired - Fee Related JP6416227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361826382P 2013-05-22 2013-05-22
US61/826,382 2013-05-22
PCT/US2014/039202 WO2014190184A1 (en) 2013-05-22 2014-05-22 Stabilized hypochlorous acid solution and use thereof

Publications (3)

Publication Number Publication Date
JP2016521684A JP2016521684A (ja) 2016-07-25
JP2016521684A5 true JP2016521684A5 (https=) 2017-06-29
JP6416227B2 JP6416227B2 (ja) 2018-10-31

Family

ID=51934166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016515094A Expired - Fee Related JP6416227B2 (ja) 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用

Country Status (6)

Country Link
US (2) US9918477B2 (https=)
EP (1) EP2999341B1 (https=)
JP (1) JP6416227B2 (https=)
CA (1) CA2913137A1 (https=)
MX (1) MX373524B (https=)
WO (1) WO2014190184A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2637178C (en) 2006-01-20 2018-09-04 Oculus Innovative Sciences, Inc. Methods of preventing or treating sinusitis with oxidative reductive potential water solution
US9918477B2 (en) * 2013-05-22 2018-03-20 Sonoma Pharmaceuticals, Inc. Stabilized hypochlorous acid solution and use thereof
EP3645017A4 (en) 2017-06-28 2021-05-19 Collidion, Inc. COMPOSITIONS, PROCEDURES AND USES FOR CLEANING UP, DISINFECTING AND / OR STERILIZATION
KR102799949B1 (ko) 2018-01-14 2025-04-23 콜리디온, 인코포레이티드 세척, 소독, 멸균 및/또는 치료를 위한 조성물, 키트, 방법 및 용도
EP3927351A4 (en) 2019-02-20 2023-01-04 Biiosmart Technologies LLC INTRAVENOUS HYPOCHLOROUS ACID SOLUTION, PREPARATION AND METHOD OF USE THEREOF
CA3167941A1 (en) 2020-02-14 2021-08-19 Collidion, Inc. Compositions, kits, methods and uses for cleaning, disinfecting, sterilizing and/or treating
LU101842B1 (en) 2020-06-08 2021-12-08 Arnaud Mainnemare Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
US11097945B1 (en) 2020-11-04 2021-08-24 Cougar Creek Electrolysed Water, Llc Methods and systems for production of an aqueous hypochlorous acid solution
IT202000028082A1 (it) 2020-11-23 2022-05-23 Md Italy Srl Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001041571A1 (en) * 1999-12-10 2001-06-14 Kao Corporation Microbicide compositions
JP3554749B2 (ja) * 2001-02-22 2004-08-18 株式会社アクシス 殺菌消毒剤
CA2553943C (en) 2003-12-30 2014-02-11 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution, processes for producing same and methods of using the same
US20050139808A1 (en) 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
US20050196462A1 (en) 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
CN101163492B (zh) 2005-03-23 2013-01-30 奥古露丝创新科学公司 利用氧化还原电位水溶液治疗2度和3度烧伤的方法
CA2602411C (en) 2005-03-23 2015-02-24 Oculus Innovative Sciences, Inc. Method of treating second and third degree burns using oxidative reductive potential water solution
CA2606734C (en) 2005-05-02 2016-06-21 Oculus Innovative Sciences, Inc. Method of using oxidative reductive potential water solution in dental applications
CA2637178C (en) 2006-01-20 2018-09-04 Oculus Innovative Sciences, Inc. Methods of preventing or treating sinusitis with oxidative reductive potential water solution
BRPI0808856B8 (pt) 2007-03-13 2021-05-25 Oculus Innovative Sciences Inc soluções antimicrobianas contendo monóxido de dicloro, seus processos de preparação e método não terapêutico para desinfetar uma superfície
WO2010148004A1 (en) 2009-06-15 2010-12-23 Oculus Innovative Sciences, Inc. Solution containing hypochlorous acid and methods of using same
WO2011014809A1 (en) 2009-07-30 2011-02-03 Oculus Innovative Sciences, Inc. Hydrogel formulation comprising oxidative reductive potential water
GB2488838A (en) * 2011-03-11 2012-09-12 Biomimetics Health Ind Ltd A stable antimicrobial aqueous hypochlorous acid solution
US9918477B2 (en) 2013-05-22 2018-03-20 Sonoma Pharmaceuticals, Inc. Stabilized hypochlorous acid solution and use thereof

Similar Documents

Publication Publication Date Title
JP2016521684A5 (https=)
JP2012530142A5 (https=)
JP2022075813A (ja) ジクアホソル含有点眼液
JP2014515737A5 (https=)
MX2020014000A (es) Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
MX2016006197A (es) Formulaciones de compuestos de azaindol.
RU2015126801A (ru) Фторид-стабильные цинкосодержащие композиции для ухода за полостью рта
JP2009523832A5 (https=)
WO2011109799A8 (en) Nuclear transport modulatiors and uses thereof
BRPI0409198A (pt) derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
JP2010514799A5 (https=)
MY161032A (en) Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
CN104488957A (zh) 循环水系统用高效复合杀菌剂及其制备方法
EP4631569A3 (en) Alginate film comprising a triptan
NZ605860A (en) Use of vitamin c, and chromium-free vitamin k or 2-methyl-1,4-naphthalendione, and compositions thereof for treating a polycystic disease
MX2015016057A (es) Solucion estabilizada de acido hipocloroso y uso de la misma.
WO2013086243A3 (en) Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease
ZA202106768B (en) Triamterene or nolatrexed for use in the treatment of phenylketonuria
BR112014004111A2 (pt) peneira molecular de silicoaluminofosfato e método de produção da mesma
JP2013509378A5 (https=)
TW200833708A (en) Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
WO2007078848A3 (en) Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid
WO2011048589A3 (en) Ion exchangers and methods of use thereof
JP2006160607A5 (https=)
WO2012169849A3 (en) Eye-drop composition for preventing or treating ocular diseases